|
Related Companies
|
[]
|
||||||||
|
Related Funds
|
[]
|
||||||||
|
|
|||||||||
|
English
|
|||||||||
|
oda_MaterialEventDisclosureGeneralAbstract|
|
|
||||||||
|
oda_UpdateAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_CorrectionAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_DateOfThePreviousNotificationAboutTheSameSubject|
|
|
-
|
|||||||
|
oda_DelayedAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_AnnouncementContentSection|
|
|
||||||||
|
oda_ExplanationSection|
|
|
||||||||
|
oda_ExplanationTextBlock|
|
MLP Sağlık Hizmetleri A.Ş. ("MLP Care") signed a share transfer agreement regarding two of its subsidiaries with MP Sağlık Hizmetleri A.Ş ("MP Sağlık") in March 16, 2022 (today). According to this share transfer agreement, MLP Care will transfer its 56% shares in Sentez Sağlık Hizmetleri A.Ş ("Sentez"), one of its subsidiaries, to MP Sağlık which is a 44% minority shareholder. MLP Care will increase its shareholding percentage from 75% to 100% by purchasing 25% of minority shareholders' shares in MS Sağlık Hizmetleri Ticaret A.Ş ("MS Sağlık"), one of its subsidiaries from MP Sağlık. The aforementioned share transfer agreement is a conditional/forward agreement, and if the Competition Board's permission is obtained and certain commercial conditions are fulfilled, the share transfers will be realized mutually. In the event that the closing procedures are carried out pursuant to the share transfer agreement, all shares of our Company in Sentez Sağlık will be transferred to the buyer, MP Sağlık. Our shareholding percentage in MS Sağlık will be increased from 75% to 100%, which makes our Company the sole shareholder. Under the subsidiary of Sentez three hospitals (İzmir, Gaziantep and Batman) are operated. Under MS Sağlık, which is the other subsidiary subject to the transfer, Liv Hospital Ankara is operated. All developments related to the transfer process will be publicly announced separately at every necessary point. It is submitted for your information. This statement has been translated into English for informational purposes. In case of a discrepancy between the Turkish and the English versions of this disclosure statement, the Turkish version shall prevail. |
||||||||